New Angiotensin Studies in COVID-19 Give More Reassurance

A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes but suggests possible differential effects of the two drug classes.

from WebMD Health https://ift.tt/2LbTUKN
via IFTTT